Ross Muken
Stock Analyst at Evercore ISI Group
(2.60)
# 2,261
Out of 5,065 analysts
47
Total ratings
57.69%
Success rate
0.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $190 → $200 | $167.64 | +19.30% | 9 | Oct 3, 2025 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $73.40 | -4.63% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $164.56 | +45.84% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $151.25 | -14.05% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $46.84 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $209.48 | -68.02% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $123.85 | +101.86% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $587.48 | -62.55% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $11.17 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Oct 3, 2025
Maintains: Outperform
Price Target: $190 → $200
Current: $167.64
Upside: +19.30%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $73.40
Upside: -4.63%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $164.56
Upside: +45.84%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $151.25
Upside: -14.05%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $46.84
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $209.48
Upside: -68.02%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $123.85
Upside: +101.86%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $587.48
Upside: -62.55%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $11.17
Upside: -